Form preview

Get the free Proprietary Name Review for Lamictal ODT - accessdata fda

Get Form
This document is a review conducted by the FDA's Division of Medication Error Prevention and Analysis focusing on the proprietary name, Lamictal ODT, assessing risks of confusion and medication errors
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign proprietary name review for

Edit
Edit your proprietary name review for form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your proprietary name review for form via URL. You can also download, print, or export forms to your preferred cloud storage service.

How to edit proprietary name review for online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Follow the guidelines below to take advantage of the professional PDF editor:
1
Log in. Click Start Free Trial and create a profile if necessary.
2
Upload a document. Select Add New on your Dashboard and transfer a file into the system in one of the following ways: by uploading it from your device or importing from the cloud, web, or internal mail. Then, click Start editing.
3
Edit proprietary name review for. Add and replace text, insert new objects, rearrange pages, add watermarks and page numbers, and more. Click Done when you are finished editing and go to the Documents tab to merge, split, lock or unlock the file.
4
Save your file. Select it in the list of your records. Then, move the cursor to the right toolbar and choose one of the available exporting methods: save it in multiple formats, download it as a PDF, send it by email, or store it in the cloud.
It's easier to work with documents with pdfFiller than you can have believed. You may try it out for yourself by signing up for an account.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out proprietary name review for

Illustration

How to fill out Proprietary Name Review for Lamictal ODT

01
Gather necessary product information, including the active ingredient (Lamotrigine) and dosage form (ODT).
02
Navigate to the Proprietary Name Review submission portal.
03
Complete the initial form with basic product details.
04
Provide a proposed proprietary name for the product, ensuring it complies with FDA guidelines.
05
Include a rationale for the proposed name, explaining its significance and relevance.
06
Submit any required supporting documents, such as labeling and packaging mock-ups.
07
Review the submission for accuracy and completeness before final submission.

Who needs Proprietary Name Review for Lamictal ODT?

01
Manufacturers developing Lamictal ODT.
02
Pharmaceutical companies seeking to market the drug.
03
Regulatory professionals ensuring compliance with FDA standards.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.0
Satisfied
21 Votes

People Also Ask about

Lamotrigine is sold under the original brand name Lamictal and it is available in generic form under many brand names worldwide.
Lamotrigine may cause serious allergic reactions affecting multiple body organs (eg, liver or kidney). Check with your doctor right away if you or your child have the following symptoms: fever, dark , headache, hives, muscle pain or stiffness, stomach pain, unusual tiredness, or yellow eyes or skin.
The study found the generic was bioequivalent to Lamictal and had similar within-patient variability, providing strong evidence that the two drugs could be used interchangeably. No significant differences in control of epileptic seizures were observed.
Lamotrigine is a medication that treats epilepsy by preventing and controlling seizures. It can also treat bipolar disorder. It works by calming overactive nerves in your body. Common brand names of this medication are Lamictal® and Subvenite®.
Lamotrigine may cause serious allergic reactions affecting multiple body organs (eg, liver or kidney). Check with your doctor right away if you or your child have the following symptoms: fever, dark , headache, hives, muscle pain or stiffness, stomach pain, unusual tiredness, or yellow eyes or skin.
Common brand names of this medication are Lamictal® and Subvenite®.
Brand name: Lamictal. Find out how lamotrigine treats epilepsy and bipolar disorder, and how to take it.
Lamotrigine is a medicine used to treat epilepsy. It can also help prevent low mood (depression) in adults with bipolar disorder. Seizures are bursts of electrical activity in the brain that temporarily affect how it works. Lamotrigine slows these electrical signals down to stop seizures.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Proprietary Name Review for Lamictal ODT is a process conducted by regulatory authorities to evaluate the proposed brand name for the medication, ensuring it is not misleading, confusingly similar to existing names, or suggesting efficacy or safety.
The manufacturer or sponsor of Lamictal ODT is required to file the Proprietary Name Review as part of their regulatory submission for marketing approval.
To fill out the Proprietary Name Review for Lamictal ODT, the applicant must provide detailed information about the proposed name, including its intended use, a rationale for the selection, and any supporting data to demonstrate its uniqueness and appropriateness.
The purpose of Proprietary Name Review for Lamictal ODT is to ensure that the name is safe for public use, does not lead to medication errors, and is easily identifiable by healthcare providers and patients.
Information that must be reported includes the proposed proprietary name, reasons for selection, analysis of potential confusion with other names, and any consumer testing results that support the name's clarity and appeal.
Fill out your proprietary name review for online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.